Max J Gordon
17PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (17)
Sort by Publication Date:
|Mar 04, 2026
A phase 1 trial of romidepsin, azacitidine, dexamethasone, and lenalidomide in relapsed or refractory T-cell lymphoma.Max J Gordon, Milos D Miljkovic, Paige Milhon
|Jun 16, 2025
The anti-CD47 antibody magrolimab with obinutuzumab and venetoclax in relapsed or refractory indolent B-cell lymphomas.Rahul Lakhotia, Christopher Melani, Stefania Pittaluga
|Apr 29, 2024
Comparison of Comorbidity Models Within a Population-Based Cohort of Older Adults With Non-Hodgkin Lymphoma.Max J Gordon, Zhigang Duan, Hui Zhao
|Mar 09, 2024
A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.Max J Gordon, Sigrid Dubois, Bonita Bryant
|Nov 20, 2023
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study.Max J Gordon, Lei Feng, Paolo Strati
Pageof 3
Frequent Collaborators
3 joint publications
Christopher Melani
2 joint publications
Rahul Lakhotia
2 joint publications
Mark Roschewski
2 joint publications
Stefania Pittaluga
2 joint publications
Alessandra Ferrajoli
2 joint publications
Elaine S Jaffe
2 joint publications
Jason R Westin
2 joint publications
Reem Karmali
2 joint publications
Narendranath Epperla
2 joint publications
Jonathon B Cohen